All Updates

All Updates

icon
Filter
Product updates
Partnerships
Google DeepMind and Isomorphic Labs unveil updated AlphaFold technology
AI Drug Discovery
May 8, 2024
This week:
Product updates
Pimax announces compact Dream Air VR headset for USD 1,900
Extended Reality
Dec 23, 2024
Funding
HuLoop raises Series A funding from Mighty Capital
Workflow Automation Platforms
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
Financial Wellness Tools
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
FinTech Infrastructure
Dec 23, 2024
Funding
Meight raises EUR 3.4 million in funding led by Cusp Capital
Smart Mobility Information
Dec 23, 2024
Regulation/policy
Desktop Metal sues Nano Dimension over merger compliance
Additive Manufacturing
Dec 23, 2024
Management news
Nexa3D scales back operations amid financial crisis
Additive Manufacturing
Dec 23, 2024
Funding
Fraction AI raises USD 6 million in pre-seed funding to scale hybrid data labeling
Machine Learning Infrastructure
Dec 23, 2024
Last week:
Partnerships
Rocket Lab launches sixth Synspective radar satellite as part of ongoing partnership
Space Travel and Exploration Tech
Dec 21, 2024
Partnerships
EHang partners with Changan Automobile to develop eVTOL aircraft for personal transportation
Passenger eVTOL Aircraft
Dec 21, 2024
AI Drug Discovery

AI Drug Discovery

May 8, 2024

Google DeepMind and Isomorphic Labs unveil updated AlphaFold technology

Product updates
Partnerships

  • Google DeepMind, together with Isomorphic Labs, has introduced a new version of its AlphaFold AI technology, which helps scientists understand the behavior of the microscopic mechanisms that drive the cells in the human body. Launched in 2018, the earlier version of AlphaFold was released in 2023 for protein study.

  • AlphaFold's primary function is to study the twisting and folding process of proteins and their interaction with other human cells. The new version, AlphaFold3, is reported to have the additional feature of predicting the behavior of other microscopic biological mechanisms, including DNA and RNA.

  • Isomorphic Labs, a subsidiary of Alphabet, is a UK-based company that aims to enhance the traditional drug discovery process through the application of AI. The company is currently building on Google DeepMind’s AI research and collaborating with pharmaceutical companies, including Eli Lilly and Novartis, to advance its AI-driven drug discovery efforts.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.